Lifestyle
- Regular physical activity
- Stress management
- Adequate sleep
Blutsenkungsgeschwindigkeit · ESR · Erythrozyten-Sedimentationsrate · Erythrocyte Sedimentation Rate
ESR quantifies the rate at which erythrocytes settle in a vertical tube over one hour, reflecting the presence of inflammation.
Reference ranges can vary based on age and sex, with higher values often seen in older adults and females.
The erythrocyte sedimentation rate (ESR), also known as Blutsenkungsgeschwindigkeit (BSG) or Erythrozyten-Sedimentationsrate, is a common hematological test that measures the rate at which red blood cells settle in a tube over a specified period. This rate is indicative of the presence of inflammation in the body, as certain proteins that increase during inflammation can cause red blood cells to clump together and settle more quickly. Clinically, ESR is used as a non-specific marker of inflammation and is often measured alongside C-reactive protein (CRP) to assess inflammatory conditions. It is particularly useful in diagnosing and monitoring diseases such as rheumatoid arthritis, systemic lupus erythematosus, and temporal arteritis. However, it lacks specificity and sensitivity, meaning it should be interpreted in conjunction with clinical findings and other laboratory tests. In the context of athletic performance, biohacking, or longevity, ESR may not be directly relevant as a performance marker but can indicate underlying inflammatory processes that could affect recovery and overall health. Elevated ESR levels can be influenced by a variety of factors, including age, sex, pregnancy, and certain medications, which can confound results. It is important to consider these factors when interpreting ESR values, and fasting is not typically required for this test. Researchers have observed that ESR can be affected by non-inflammatory conditions such as anemia and hyperlipidemia, which may lead to misinterpretation if not accounted for.
Klinische Bedeutung
Elevated ESR values indicate the presence of inflammation, which can be due to infections, autoimmune diseases, or chronic inflammatory conditions. Low ESR values are generally not clinically significant but can occur in conditions such as polycythemia or extreme leukocytosis.
Progressively rising ESR values suggest worsening inflammation or infection. Re-test in 4 weeks if values are outside the optimal range.
Falling ESR values indicate a reduction in inflammation, which may reflect effective treatment or resolution of an inflammatory condition.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any supplementation, especially if you have underlying health conditions.
Testing Frequency
As needed based on clinical symptoms or monitoring of known inflammatory conditions.
Correlated with
Current research suggests that the reference ranges and optimal targets for serum semaphorin 3A (Sema 3A) in ankylosing spondylitis remain debated, particularly regarding its predictive value compared to traditional markers like ESR and CRP. Researchers have not yet established the full clinical implications of Sema 3A fluctuations during anti-TNF therapy. Unanswered clinical questions include the biomarker's role in predicting extra-articular manifestations and its utility in monitoring disease activity across diverse inflammatory conditions.
769
Total Citations
15
Human/RCT
5.5
Avg. Influence
2025
Latest
Bray Christopher, et al. · WMJ : official publication of the State Medical Society of Wisconsin · 2016
This study examined the relevance of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as markers of systemic inflammation. Researchers found that these markers lack sensitivity and specificity and should be used alongside clinical assessments for accurate diagnosis and monitoring of diseases. Discrepancies between ESR and CRP readings were noted, particularly in chronic inflammatory conditions.
Key findings
This review focused on the challenges of diagnosing inflammatory bowel disease (IBD) and the search for ideal biomarkers. Researchers observed that current biomarkers, including CRP and ESR, are not ideal and that ongoing studies aim to identify better options for IBD management.
Inciarte-Mundo José, et al. · Frontiers in immunology · 2022
This study focused on calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis (RA). Researchers found that higher calprotectin levels correlate better with disease activity than CRP or ESR. Additionally, calprotectin levels decreased after treatment, indicating its potential as a biomarker for monitoring RA.
Key findings
This review explored the interaction between cyclophilin A and CD147 in cancer. Researchers observed a significant association between the overexpression of genes encoding these proteins and poor prognosis in various tumors, suggesting their potential as therapeutic targets.
This review highlighted the importance of biomarkers in rheumatoid arthritis for diagnosis and management. Researchers noted ongoing investigations into both established and potential new biomarkers to improve clinical outcomes for RA patients.
Researchers investigated the anti-inflammatory effects of remimazolam, a new anesthetic, in a clinical setting. They found that remimazolam exhibited antioxidant properties and resulted in significantly lower postoperative CRP levels compared to dexmedetomidine. This suggests that remimazolam may have stronger anti-inflammatory effects during surgery.
Researchers conducted a systematic review to assess the frequency and significance of elevated IgG4 levels in rheumatoid arthritis (RA). They found a significant correlation between IgG4 levels and disease activity, as well as inflammatory markers like ESR and CRP. The review suggests that IgG4 may serve as a promising biomarker for monitoring RA.
This systematic review identified that elevated ESR or CRP levels are associated with systemic involvement in Degos disease. Researchers found that these markers could help predict the prognosis of patients with malignant forms of the disease.
This study assessed ocular involvement in Kawasaki disease and its relationship with other clinical and laboratory findings. Researchers found that higher neutrophil counts and CRP levels were associated with uveitis in these patients, indicating a potential link between ocular symptoms and inflammation.
This review discussed the role of laboratory tests in diagnosing systemic vasculitis. Researchers noted that while ESR and CRP are commonly used, they are nonspecific and cannot differentiate between vasculitis activity and other inflammatory conditions.
Research publications about BSG over time
7totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer